Sampling Human

📍 Berkeley, United States🗓 Founded 2022👥 14 employees💰 Last funded Oct 2024
Biotechnology Research🌐 samplinghuman.com
Website LinkedIn
The mission of Sampling Human is to couple health related decisions to their effects at the single cell level. It is inspired by the founders’ academic and professional efforts to extend what is measurable and to derive what must be measured. The human body is a complex system that cannot be quantified exhaustively or heuristically. Clinical diagnosis today is an imprecise art. On average, diagnosis of rare diseases is 5 years delayed with 50% of delays impacting the outcome. Misdiagnosis is far too common with a 66% likelihood of disagreement between experts. We are stuck with symptoms based medicine. The nature of physiological data is to blame. Decisions today are based on fuzzy variables (tired, drowsy, weak, tingling, itchy, etc). Better decisions will require precise knowledge regarding the fundamental physiological units of our bodies, CELLS.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sampling Human?
Sampling Human has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Sampling Human last raise funding?
The most recent investment in Sampling Human recorded on gritt.io was in October 2024.
When was Sampling Human founded?
Sampling Human was founded in 2022.
What industry is Sampling Human in?
Sampling Human operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sampling Human based?
Sampling Human is headquartered in Berkeley, United States.